NCT07244107 Agility and Sprint Performance in Youth Soccer: A Comparison of FIFA 11+ and RAMP Protocols
| NCT ID | NCT07244107 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Children, Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-10-22 |
| Primary Completion | 2026-06-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-10-22 with a primary completion date of 2026-06-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial investigates the comparative effects of the FIFA 11+ and RAMP (Raise, Activate, Mobilize, Potentiate) warm-up protocols on the agility and sprint performance of young soccer players. The study involves 34 male players aged 8 to 15, who will be randomly assigned to one of the two warm-up groups for a six-week intervention period. Key performance outcomes-agility, measured by the Illinois Agility Test, and sprint speed, measured by a 30-meter sprint test-will be assessed both before and after the intervention. The research aims to address a gap in sports science by directly comparing these two popular protocols in a youth population, with the goal of providing coaches with clear, evidence-based recommendations for optimizing athlete development and reducing injury risk. Data will be analyzed through SPSS version 27.00.
Eligibility Criteria
Inclusion Criteria: * Male, aged 8-15 years. * Minimum one year of organized soccer experience. * Currently training at least three times per week. * Willingness to participate and provide informed consent. Exclusion Criteria: * Cardiovascular, neurological, or musculoskeletal disorders. * Musculoskeletal injury in the past six months. * Participation in other structured injury prevention or strength programs. * Inability to complete baseline testing.
Contact & Investigator
Adil Munir, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07244107 clinical trial?
This trial is open to male participants only, aged 8 Years or older, up to 15 Years, studying Children, Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07244107 currently recruiting?
Yes, NCT07244107 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07244107 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07244107 clinical trial?
NCT07244107 is sponsored by Riphah International University. The principal investigator is Adil Munir, MS-PT at Riphah International University. The trial plans to enroll 34 participants.